tradingkey.logo
tradingkey.logo
Buscar

Artivion Inc

AORT
Añadir a la lista de seguimiento
23.970USD
+0.420+1.78%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
1.16BCap. mercado
93.41P/E TTM

Más Datos de Artivion Inc Compañía

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Información de Artivion Inc

Símbolo de cotizaciónAORT
Nombre de la empresaArtivion Inc
Fecha de salida a bolsaFeb 12, 1993
Director ejecutivoMackin (James Patrick)
Número de empleados1600
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 12
Dirección1655 Roberts Boulevard N W
CiudadKENNESAW
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal30144
Teléfono17704193355
Sitio Webhttps://artivion.com/
Símbolo de cotizaciónAORT
Fecha de salida a bolsaFeb 12, 1993
Director ejecutivoMackin (James Patrick)

Ejecutivos de Artivion Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
76.22K
+9.94%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
61.37K
+12.34%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
60.26K
+44.40%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
39.13K
+34.61%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Artivion Inc?

Los cinco principales accionistas de Artivion Inc son: Mr. John E. Davis

¿Cuántas instituciones poseen acciones de Artivion Inc (AORT)?

A fecha de 2026Q1, 449 instituciones poseen acciones de Artivion Inc, con un valor de mercado combinado de aproximadamente 45.29M, lo que representa el 93.40% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 501666.00.

¿Cuál es la mayor fuente de ganancias de Artivion Inc?

El 2026Q1, el segmento empresarial Aortic stent grafts generó la ganancia más alta para Artivion Inc, ascendiendo a 159.37M y representando el 36.11% de la ganancia total.